Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank27
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P27
Within normal range
Average
1.93%
Historical baseline
PeriodValue
Q4 20250.00%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 2024100.00%
Q2 2024-36.84%
Q1 2024-100.00%
Q4 20230.00%
Q3 2023100.00%
Q2 2023-40.00%
Q1 20230.00%